- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Sysco Corporation: Sysco Declares Increase to Quarterly Dividend Payment | ||
| Fr | Celularity Inc.: Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | ||
| Fr | Tree Island Steel Ltd.: Tree Island Steel Provides Update on Annual General Meeting of Shareholders | ||
| Fr | Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Zacatecas Silver Corp.: Zacatecas Silver Announces Investor Relations Engagement | ||
| Fr | Sonoco Products Company: Sonoco To Report First Quarter 2026 Results | ||
| Fr | ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules | ||
| Fr | Vera Bradley, Inc.: Vera Bradley Terminates Existing Shareholder Rights Plan | ||
| Fr | QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option | ||
| Fr | 4D Molecular Therapeutics, Inc.: 4DMT Announces New Employment Inducement Grants | ||
| Fr | SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders | ||
| Fr | ORIC Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting | ||
| Fr | Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 | ||
| Fr | Talen Energy Corporation: Talen Energy Announces Pricing of Senior Notes | ||
| Fr | CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Revolution Medicines, Inc.: Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | ||
| Fr | Xilio Therapeutics, Inc.: Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 | ||
| Fr | Adagene Inc.: Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types | ||
| Fr | Cardiff Oncology, Inc.: Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting | ||
| Fr | New Era Energy & Digital, Inc.: New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer | ||
| Fr | Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting | ||
| Fr | Hingham Institution for Savings: Hingham Savings Reports First Quarter 2026 Results | ||
| Fr | Acrivon Therapeutics, Inc: Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities | ||
| Fr | NEXGEL, INC.: NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET | ||
| Fr | Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.